PMC:7195088 / 10530-10934 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"172","span":{"begin":62,"end":70},"obj":"Species"},{"id":"245","span":{"begin":34,"end":42},"obj":"Disease"}],"attributes":[{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"Tax:9606"},{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"umab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreviewed cases series) and that it only supports a potential favourable effect on inflammatory signs and symptoms, while there is no information on any possible effect on survival. I"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T54","span":{"begin":34,"end":42},"obj":"Disease"}],"attributes":[{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"umab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreviewed cases series) and that it only supports a potential favourable effect on inflammatory signs and symptoms, while there is no information on any possible effect on survival. I"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T35","span":{"begin":131,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T36","span":{"begin":137,"end":141},"obj":"http://purl.obolibrary.org/obo/CLO_0008416"},{"id":"T37","span":{"begin":137,"end":141},"obj":"http://purl.obolibrary.org/obo/CLO_0050081"},{"id":"T38","span":{"begin":271,"end":272},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"umab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreviewed cases series) and that it only supports a potential favourable effect on inflammatory signs and symptoms, while there is no information on any possible effect on survival. I"}